BioCorRx (BICX) FCF Margin (2011 - 2026)

BioCorRx (BICX) posted FCF Margin of 201.81% for Q1 2026, up 35.68% sequentially from 313.74% in Q4 2025, and up 30940.0% YoY from N/an in Q1 2025.

BioCorRx (BICX) FCF Margin (2011 - 2026) Analysis & Trends

BioCorRx has reported FCF Margin for 16 years, with the latest figure at 201.81% in Q1 2026.

Quarterly FCF Margin rose 30940.0% year-over-year to 201.81% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 157.27% (up 88359.0% YoY) and the FY2025 annual result came in at 288.28%, up 1401379.0% from the prior year.
FCF Margin rose to 201.81% in Q1 2026 per BICX's latest filing, from 313.74% in the prior quarter.
Over five years, FCF Margin peaked at 70.97% in Q2 2025 and troughed at 9383.09% in Q1 2024.
A 5-year average of 2125.73% and a median of 982.53% in 2023 frame the typical range for FCF Margin.
The sharpest annual moves came in 2024 and 2025: FCF Margin sank 840056 bps in 2024, then soared 887188 bps in 2025.
Over 5 years, FCF Margin stood at 542.44% in 2022, then plunged by 420 bps to 2818.86% in 2023, then tumbled by 33 bps to 3754.59% in 2024, then soared by 92 bps to 313.74% in 2025, then surged by 36 bps to 201.81% in 2026.
According to Business Quant data, FCF Margin over the past three periods registered 201.81%, 313.74%, and 99.88% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Margin (Qtr)
1	HCA Healthcare	88.19 Bn	90.61 Bn	15.19 Bn	5.46%
2	Tenet Healthcare	21.59 Bn	21.56 Bn	4.45 Bn	7.41%
3	Encompass Health	12.19 Bn	12.86 Bn	1.34 Bn	3.90%
4	Davita	11.52 Bn	12.39 Bn	1.16 Bn	9.01%
5	Ensign	10.59 Bn	10.27 Bn	306.24 Mn	8.27%
6	Universal Health Services	8.79 Bn	8.72 Bn	3.29 Bn	4.65%
7	Pacs	7.04 Bn	6.88 Bn	338.46 Mn	2.19%
8	Chemed	6.96 Bn	6.92 Bn	221.47 Mn	10.29%
9	Concentra Group Holdings Parent	4.52 Bn	4.38 Bn	192.10 Mn	19.73%
10	BioCorRx	1.49 Mn	1.47 Mn	-	-

Download Data